Evidence map›Paper›PMID 36099236›Full record

ArticlePloS one2022

Antibacterial activity of medicinal plants in Indonesia on Streptococcus pneumoniae.

Wisnu Tafroji, Nur Ita Margyaningsih, Miftahuddin Majid Khoeri, Wisiva Tofriska Paramaiswari, Yayah Winarti, Korrie Salsabila, Hanifah Fajri Maharani Putri, Nurjati Chairani Siregar, Amin Soebandrio, Dodi Safari

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Wisnu TafrojiEijkman Institute for Molecular Biology, Jakarta, Indonesia.ORCID 0000-0003-0622-7022
Nur Ita MargyaningsihEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Miftahuddin Majid KhoeriEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Wisiva Tofriska ParamaiswariEijkman Institute for Molecular Biology, Jakarta, Indonesia.ORCID 0000-0003-2808-5248
Yayah WinartiEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Korrie SalsabilaEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Hanifah Fajri Maharani PutriEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Nurjati Chairani SiregarEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Amin SoebandrioEijkman Institute for Molecular Biology, Jakarta, Indonesia.ORCID 0000-0002-5856-4808
Dodi SafariEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Eijkman Institute for Molecular Biology · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus pneumoniae is a human pathogenic bacterium able to cause invasive pneumococcal diseases. Some studies have reported medicinal plants having antibacterial activity against pathogenic bacteria. However, antibacterial studies of medicinal plants against S. pneumoniae remains limited. Therefore, this study aims to describe the antibacterial activity of medicinal plants in Indonesia against S. pneumoniae. Medicinal plants were extracted by maceration with n-hexane, ethanol, ethyl acetate and water. Antibacterial activity was defined by inhibition zone and minimum inhibitory concentration (MIC). Bactericidal activity was measured by culture and time-killing measurement. Methods used to describe the mechanism of action of the strongest extract were done by absorbance at 595 nm, broth culture combined with 1% crystal violet, qRT-PCR targeting lytA, peZT and peZA, and transmission electron microscope to measure bacterial lysis, antibiofilm, LytA and peZAT gene expression, and ultrastructure changes respectively. Among 13 medicinal plants, L. inermis Linn. ethyl acetate extract showed the strongest antibacterial activity against S. pneumoniae with an MIC value of 0,16 mg/ml. Bactericidal activity was observed at 0,16 mg/ml for 1 hour incubation. Lawsonia inermis extract showed some mechanism of actions including bacterial lysis, antibiofilm, and ultrastructure changes such as cell wall disruption, decreasing cell membrane integrity and morphological disorder. Increasing of lytA and decreasing of peZA and peZT expression were also observed after incubation with the extract. In addition, liquid chromatography mass spectrophotometer showed phenolic compounds as the commonest compound in L. inermis ethyl acetate extract. This study describes the strong antibacterial activity of L. inermis with various mechanism of action including ultrastructure changes.

Indexed as

Plants, MedicinalAcetatesAnti-Bacterial AgentsBacteriaHumansIndonesiaPlant ExtractsStreptococcus pneumoniaeAcetatesAnti-Bacterial Agentsethyl acetatePlant Extracts

Identifiers

PMID36099236
PMCPMC9469987
OpenAlexW4295422352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.